IT-901

N/A

Report date: 2023/09/11 14:03:41
NME

Base Information

Drug NameIT-901
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProto-oncogene c-Rel inhibitors
TargetsProto-oncogene c-Rel
Therapy Area/IndicationsGraft vs Host DiseaseMultiple SclerosisMultiple Myeloma +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmuneTarget Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmuneTarget Inc
Active IndicationsN/A
Inactive IndicationsGraft vs Host DiseaseMultiple SclerosisMultiple Myeloma +[5] 

Other Information

ATC CodeN/A
Related LinksN/A